Together with my then girlfriend and now wife, we took a year off from our hectic lives to travel and embrace a world beyond our previous experiences. It was an astonishing adventure.If you are interested in our journey the blog we created can be found at: www.roderickphillips.com

Developed and maintained relationships with Key Opinion Leaders (KOLs), Healthcare Professionals (HCPs), and Primary Investigators (PIs). Supported Amgen’s marketed oncology products and the oncology pipeline program in Northern California.Engaged in bilateral scientific exchange with KOLs and disseminated information to the RML senior leadership team.Addressed formulary / P&T issues.Conducted extensive disease state education programs and KOL profiling around the launch of Vectibix, Nplate, and Prolia.Research Support:Identified sites for clinical trial participation Supported ongoing studies with educational presentationsConducted data-sharing programs on completed trials.Congress Support:Interacted with OLs, HCPs, and PIs at the Scientific Affairs booth (around new data, clinical trial opportunities, and the oncology pipeline)Evaluated data sets from poster / oral presentations and in collaboration with Med Com provided daily reports to Amgen’s internal stakeholdersCollected competitive information for internal assessmentSpeaker Support:Identified and trained promotional speakers on Amgen’s portfolio of marketed oncology products Provided updates to speakers as new data became availableAssessed speaker performances and refined their skill sets as appropriateInvestigator-sponsored Studies / Cooperative StudiesLeveraged Amgen’s enthusiasm for academic collaboration to organize a research symposium enabling the SWOG gynecology / oncology committee and internal stakeholders within Amgen to develop mutually beneficial clinical trials. protocols.

Cross-functional collaboration with Medical Affairs, Clinical Operations and Research to promote awareness of the company and its drugs within the Idiopathic Pulmonary Fibrosis (IPF) community. Developed: KOL relationshipsMarketing and publication strategyEducational presentations, andEvaluated Investigator Sponsored Trials.Organized and facilitated a multi-day retreat for KOLs and senior management to exchange information and strategize over next generation therapeutics for IPF.Lectured at National Ad Boards and presented novel data at major, peer-reviewed scientific congresses.Managed a drug candidate program for the IPF group: Conceived the experimental design, identified vendors to support the program, troubleshot problems, interpreted data, and made recommendations to senior management.